DXS, the personalised medicine company, has announced the appointment of Vicki Wilson as diagnostics product manager.
Wilson will be responsible for managing DXS' portfolio of tumour mutation analysis products, such as the TheraScreen assays for K-RAS and EGFR mutations.
Vicki joins DXS from Invitrogen, where she was a key account manager.
She has also previously worked for Bayer Diagnostics, Tecan and Dade Baring in a variety of roles, including account management, technical support and training.
